Bank of New York Mellon Corp Cuts Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Bank of New York Mellon Corp decreased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 13.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 960,450 shares of the company's stock after selling 143,133 shares during the period. Bank of New York Mellon Corp owned about 1.04% of Acadia Healthcare worth $29,121,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ACHC. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after purchasing an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Acadia Healthcare in the first quarter valued at approximately $222,000. Sterling Capital Management LLC grew its position in shares of Acadia Healthcare by 59.1% in the fourth quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock valued at $216,000 after purchasing an additional 2,026 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $5,134,000. Finally, Russell Investments Group Ltd. grew its position in shares of Acadia Healthcare by 21.4% in the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after purchasing an additional 3,248 shares during the last quarter.

Acadia Healthcare Trading Down 3.7%

Shares of ACHC stock traded down $0.85 during mid-day trading on Friday, hitting $21.92. The company's stock had a trading volume of 1,278,458 shares, compared to its average volume of 1,870,740. The company's fifty day simple moving average is $23.07 and its 200-day simple moving average is $30.14. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $2.02 billion, a PE ratio of 10.80, a P/E/G ratio of 4.18 and a beta of 0.93.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The company's quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.84 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have weighed in on ACHC. Stephens raised Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. KeyCorp reduced their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Barclays reduced their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th. Finally, Mizuho cut their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.